Integrated Biosciences joins Illumina Ventures Labs to design novel therapeutics targeting the transcriptome.

We are Integrated Biosciences.

Cellular rejuvenation with optogenetics and small molecules

We combine synthetic biology and machine learning to control cellular stress responses for next-generation therapeutics.

The Targets

Cellular stress responses contribute to diseases including neurodegeneration, cancer, diabetes, osteoarthritis, and other age-associated diseases. Targeting these stress responses with small molecule therapeutics is disease-modifying and will help to mediate healthy aging.

The Technology

Our proprietary synthetic biology technology allows us to virtually activate cellular stress responses, discover drugs targeting stressed cells, and rapidly identify drug targets. We have also developed next-generation deep learning approaches to identifying small molecules that will accelerate our discovery efforts.